SYNLAB UK & Ireland:

Official Notice – Long-haul COVID Testing

Published: 12th March 2022 - All information correct at time of publication.

Update on SYNLAB position re: long-haul COVID testing services in the UK

With events unfolding in the last few hours, we are issuing this independent statement aimed at people affected by this week’s issues, as well as those suffering from long-term COVID-related illnesses. At SYNLAB, we are unwavering in our commitment to providing high quality testing and diagnostic services which centre’s on the needs of people and consumers, and we pride ourselves on our professionalism and integrity.

We re-emphasise our earlier statement that SYNLAB did not at any time agree to, support or endorse the clinic being arranged on Monday 14 March in Bristol by another party. At the point at which clinics were promoted in our name and without our consent, discussions were still very much under way about how we could put in place arrangements which meet the necessary standards and regulations. It may seem like a simple thing to achieve, but setting up a service which is safe, legitimate and effective can take weeks, if not months – especially when it needs to involve multiple organisations, which is the case for this particular test.

We very much regret the distress that all of this will have caused to people affected by long-term COVID illnesses, particularly those whose hopes were raised about taking the test in the UK next week.

With this community in mind, SYNLAB remains committed to doing everything we can to support the introduction of long-COVID testing in the UK; and we are wholly supportive and encouraging of other organisations who may be able to introduce this particular testing service instead. Our primary concern is for this vulnerable group of people, it is not one of commercial interest.

I would add that we had been making good progress in exploring a possible solution in collaboration with other parties, and we will continue our discussions within SYNLAB.

What has happened over the last week has been very disappointing for all of us at SYNLAB – as we know it will have been for those struggling with long-term COVID illnesses. Developing testing services to help diagnose and treat chronic illness associated with COVID is a truly important mission, and one which we wholeheartedly support.

Mark Dollar
Chief Executive
SYNLAB UK & Ireland

Mark Dollar
Latest SYNLAB UK & Ireland News
SYNLAB UK&I appoints new Synnovis CEO

SYNLAB UK & Ireland is delighted to announce the appointment of Tom Evans as Chief Executive Officer of Synnovis, its NHS partnership in South East…

Read More (about 'SYNLAB UK&I appoints new Synnovis CEO')
SYNLAB UK & Ireland partners with iFAST Diagnostics

We are proud to announce the expansion of our partnership with iFAST Diagnostics as its first commercial laboratory partner in the UK. Following validation earlier…

Read More (about 'SYNLAB UK & Ireland partners with iFAST Diagnostics')
SYNLAB UK & Ireland announces new Chief Medical Officer

SYNLAB UK & Ireland is delighted to announce the appointment of Dr John Burke as Chief Medical Officer. This appointment is pivotal to the advancement…

Read More (about 'SYNLAB UK & Ireland announces new Chief Medical Officer')
iFAST Diagnostics

We are proud to be partnering with iFAST Diagnostics to evaluate their new antimicrobial susceptibility testing (AST) system. The low-cost, high-throughput, bench top device can…

Read More (about 'iFAST Diagnostics')
Synnovis Logo
Synnovis completes forensic review following 2024 cyberattack — notifications under way

Synnovis, a pathology partnership between Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospitals NHS Trust and SYNLAB, has completed the forensic investigation of…

Read More (about 'Synnovis completes forensic review following 2024 cyberattack — notifications under way')
A single pathology service for mid and south Essex is confirmed from October 2026

Mid and South Essex NHS Foundation Trust has signed a 15-year contract with SYNLAB, one of UK’s leading laboratory diagnostics providers, for the delivery of…

Read More (about 'A single pathology service for mid and south Essex is confirmed from October 2026')
The Christie NHS Foundation Trust & SYNLAB announce new 15+ year contract

The Christie NHS Foundation Trust has signed a 15+ year contract with SYNLAB, the leading provider of medical diagnostic services and specialty testing in Europe,…

Read More (about 'The Christie NHS Foundation Trust & SYNLAB announce new 15+ year contract')
SYNLAB Chosen as Preferred Pathology Services Supplier for Mid and South Essex

Patients across mid and south Essex are set to benefit from a single provider of pathology services, following an intensive and competitive procurement process. SYNLAB,…

Read More (about 'SYNLAB Chosen as Preferred Pathology Services Supplier for Mid and South Essex')
SYNLAB Values Wheel
SYNLAB sets its Sights on Becoming the UK’s Leading Laboratory Diagnostics Organisation

Science for Life, Health and Wellbeing SYNLAB, the medical diagnostics provider, has set out its ambition to become the UK’s leading  laboratory diagnostics organisation by…

Read More (about 'SYNLAB sets its Sights on Becoming the UK’s Leading Laboratory Diagnostics Organisation')
Landmark Day for Pathology Partnership with Launch of Synnovis Brand

A pathology partnership performing 32 million tests a year has been relaunched as ‘Synnovis’ – officially heralding the start of a new era for clinicians…

Read More (about 'Landmark Day for Pathology Partnership with Launch of Synnovis Brand')
Pathology laboratory becomes the first in the UK to support remote plate reading  

A pathology laboratory is leading the way in speeding up access to patient care and treatment after becoming the first in the UK to enable…

Read More (about 'Pathology laboratory becomes the first in the UK to support remote plate reading  ')
SYNLAB ESG Roadmap and Framework

Introduction SYNLAB UK&I is thrilled to publish its UK&I ESG Framework and Roadmap, which outlines out how we will achieve our ESG Goals. In it…

Read More (about 'SYNLAB ESG Roadmap and Framework')